Sulfotanshinone sodium

丹参酮ⅡA磺酸钠

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSulfotanshinone sodium
Drug Alias NameSulfotanshinone sodium injection诺新康
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsMyocardial InfarctionCoronary DiseaseAngina Pectoris
Global Approved IndicationsMyocardial InfarctionCoronary DiseaseAngina Pectoris
Approved Indications in ChinaMyocardial InfarctionCoronary DiseaseAngina Pectoris
Original Approved Country/TerritoryMainland China
Original Approved Date1995/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Active IndicationsMyocardial InfarctionCoronary DiseaseAngina Pectoris
Inactive IndicationsN/A

Other Information

ATC CodeC01
Related LinksN/A